ELEMENTIS PLC/ADR (OTCMKTS:ELMTY) Stock Rating Upgraded by Zacks Investment Research

ELEMENTIS PLC/ADR (OTCMKTS:ELMTY) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Friday, Zacks.com reports.

According to Zacks, “Elementis plc is a specialty chemicals company. Its business comprises of Specialty Products, Chromium and Surfactants. The company’s product consists of BENTONE(R) organoclays, RHEOLATE(R) rheological additives, DAPRO(R) specialty additives, M-P-A(R) anti-settling agents, NALZIN(R) corrosion and rust inhibitors, THIXATROL(R) rheology additives, NUOSPERSE(R) wetting and dispersing agents, TINT-AYD (R)colorants, SLIP-AYD(R) waxes and slip additives, SERDOX(R) polyglycol ethers, SERDOLAMIDE(R) alkanolamides and SERVOXYL(R) phosphate esters. Elementis plc is based in London, United Kingdom. “

OTCMKTS ELMTY remained flat at $$7.00 during trading hours on Friday. The company had a trading volume of 500 shares, compared to its average volume of 25. ELEMENTIS PLC/ADR has a 52-week low of $7.00 and a 52-week high of $9.14. The stock has a market cap of $1.02 billion, a P/E ratio of 10.29 and a beta of 1.04. The business’s fifty day moving average is $8.63 and its 200 day moving average is $7.76.


Elementis plc manufactures and sells specialty chemicals in North and South America, Europe, and Asia. It operates through Specialty Products and Chromium segments. The Specialty Products segment offers functional additives to the personal care, coatings, and energy end markets, as well as oilfield and construction sectors.

Read More: The limitations of an equal weight rating

Get a free copy of the Zacks research report on ELEMENTIS PLC/ADR (ELMTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for ELEMENTIS PLC/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ELEMENTIS PLC/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News